INVESTIGATION ALERT: Halper Sadeh LLP Investigates MLND, PEBO, DSSI, BMTC, JCS; Shareholders are Encouraged to Contact the Firm

Stock Information for null

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About null

Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting
Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications
Tempest Reports Year End 2023 Financial Results and Provides Business Update
Glancy Prongay & Murray LLP Announces Investigation of Tempest Therapeutics, Inc. (TPST)
Tempest Presents New Data at the SITC 2024 Spring Scientific Meeting Supporting Potent Anti-tumor Activity of TPST-1120 in Multiple Cancer Types
Tempest Announces Upcoming Presentation of Preclinical Data for TPST-1120 in Renal Cell Carcinoma at the AACR Annual Meeting
Tempest to Present at the 44th Annual TD Cowen Healthcare Conference
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.